Arbutus Biopharma Corp (ABUS) — Financial Flexibility Index
Arbutus Biopharma Corp (ABUS) has a Financial Flexibility Index of -0.26x as of December 2025. Free cash flow of $-4.68 Million (operating CF $-4.68 Million minus capex $4.00) represents 0% of total liabilities ($18.04 Million). Also explore Arbutus Biopharma Corp net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arbutus Biopharma Corp Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Arbutus Biopharma Corp across 28 annual periods. Check strategic asset allocation of Arbutus Biopharma Corp to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Arbutus Biopharma Corp (1998–2025)
Year-by-year free cash flow to debt coverage for Arbutus Biopharma Corp. For the full company profile including market capitalisation, see ABUS market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-39.64 Million | $-39.64 Million | $18.04 Million | ▼ -16.7% |
| 2024 | -1.88x | $-64.67 Million | $-64.85 Million | $34.34 Million | ▲ +14.9% |
| 2023 | -2.21x | $-84.93 Million | $-85.94 Million | $38.38 Million | ▼ -271.9% |
| 2022 | -0.59x | $-34.84 Million | $-35.36 Million | $58.57 Million | ▲ +68.8% |
| 2021 | -1.90x | $-66.72 Million | $-67.53 Million | $35.05 Million | ▼ -30.5% |
| 2020 | -1.46x | $-51.21 Million | $-51.44 Million | $35.11 Million | ▲ +32.1% |
| 2019 | -2.15x | $-70.42 Million | $-71.01 Million | $32.79 Million | ▲ +11.0% |
| 2018 | -2.41x | $-66.76 Million | $-67.90 Million | $27.67 Million | ▼ -219.3% |
| 2017 | -0.76x | $-41.34 Million | $-48.60 Million | $54.70 Million | ▼ -2.2% |
| 2016 | -0.74x | $-53.89 Million | $-57.88 Million | $72.90 Million | ▼ -131.8% |
| 2015 | -0.32x | $-52.50 Million | $-54.78 Million | $164.61 Million | ▲ +15.3% |
| 2014 | -0.38x | $-11.37 Million | $-12.42 Million | $30.20 Million | ▲ +21.6% |
| 2013 | -0.48x | $-6.01 Million | $-6.74 Million | $12.52 Million | ▼ -116.8% |
| 2012 | 2.85x | $33.29 Million | $33.27 Million | $11.68 Million | ▲ +424.6% |
| 2011 | -0.88x | $-7.46 Million | $-7.52 Million | $8.50 Million | ▲ +13.3% |
| 2010 | -1.01x | $-10.42 Million | $-11.25 Million | $10.29 Million | ▼ -82.3% |
| 2009 | -0.56x | $-3.62 Million | $-5.24 Million | $6.51 Million | ▲ +70.1% |
| 2008 | -1.85x | $-7.52 Million | $-8.48 Million | $4.05 Million | ▼ -784.4% |
| 2007 | -0.21x | $-1.36 Million | $-2.72 Million | $6.46 Million | ▲ +51.2% |
| 2006 | -0.43x | $-2.53 Million | $-2.62 Million | $5.88 Million | ▼ -9.5% |
| 2005 | -0.39x | $-14.53 Million | $-14.57 Million | $36.99 Million | ▼ -615.2% |
| 2004 | -0.05x | $-2.83 Million | $-9.98 Million | $51.60 Million | ▲ +98.5% |
| 2003 | -3.56x | $-26.18 Million | $-26.96 Million | $7.35 Million | ▼ -73.0% |
| 2002 | -2.06x | $-16.21 Million | $-18.16 Million | $7.87 Million | ▼ -39.1% |
| 2001 | -1.48x | $-9.06 Million | $-10.00 Million | $6.12 Million | ▲ +54.7% |
| 2000 | -3.27x | $-8.15 Million | $-8.35 Million | $2.49 Million | ▲ +4.0% |
| 1999 | -3.40x | $-6.54 Million | $-6.84 Million | $1.92 Million | ▼ -6.6% |
| 1998 | -3.19x | $-4.49 Million | $-7.71 Million | $1.40 Million | — |